ArticleMolecular cancer2013

Novel microRNA-based assay demonstrates 92% agreement with diagnosis based on clinicopathologic and management data in a cohort of patients with carcinoma of unknown primary.

George Pentheroudakis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.